Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
Ayaka Sato, Hodaka Nagai, Ayano Suzuki, Aya Ito, Shimpei Matsuyama, Nagito Shibui, Masashi Morita, Mari Hikosaka-Kuniishi, Naoto Ishii, Takanori So · 2025
Read Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes by Ayaka Sato, Hodaka Nagai, Ayano Suzuki, Aya Ito, Shimpei Matsuyama, Nagito Shibui, Masashi Morita, Mari Hikosaka-Kuniishi, Naoto Ishii, Takanori So (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11757143.txt.
Description
Ayaka Sato and co-authors engineered a soluble protein that switches on a T cell growth signal, in a study published in 2024. The signal comes from OX40, a receptor that appears on active T cells and boosts their growth and survival. Its natural partner sits fixed on cell surfaces, which makes it hard to copy as a drug. The team built stand-in proteins with parts that cluster the partner into effective groups.
Their proteins bound the receptor, fired its internal pathway, and made T cells release signaling molecules in dishes. In mice, one design strongly expanded the T cells matched to a test antigen. Sister designs carrying partners for three other receptors worked in the same way. The authors say tuned clustering may yield stronger immune therapy agents.
Catalog record
| CREATOR | Ayaka Sato, Hodaka Nagai, Ayano Suzuki, Aya Ito, Shimpei Matsuyama, Nagito Shibui, Masashi Morita, Mari Hikosaka-Kuniishi, Naoto Ishii, Takanori So |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |